Twenty-seven paired maternal-cord sera were analyzed for serum triiodothyronine (T3), total serum thyroxine (TT4), and maximum thyroxine globulin binding capacity (TBG cap.). In 17 of the infants the same studies were repeated at 1 week of age and in 10 of the 17 at 1 month. The mean T 3 value for the cord sera was 73.1 ± 20.4 ng/100 ml while the mean value for the maternal sera was 204 ± 49.2. The difference in the mean values was highly significant (P < 0.001). The maternal T 3 values are comparable with those of nonpregnant control subjects; those of cord blood fall below normal values. No statistically significant difference was found between the TT4 and TBG cap. values for cord and maternal sera. Both values were higher than the normal nonpregnant control values. At 1 week of age the serum T 3 levels had increased to a mean of 208.4 ± 40.9 ng/100 ml. This mean is significantly different from the one observed in cord sera (P < 0.001). A significant increase in the TT 4 values, mean 12.53 ± 2.2 Mg/100 ml (P < 0.01), was observed by the end of the 1st week. TBG cap. did not change significantly between birth and 1 week of age; by the end of the 1st month of life the serum TT 4 had decreased significantly to a mean of 9.5 ± 2.7 Mg/100 ml (P < 0.05), while the serum T 3 was maintained at a mean level of 228.2 ± 16.9 ng/100 ml, a value not significantly different from the one observed at 1 week of age.
Extract
Twenty-seven paired maternal-cord sera were analyzed for serum triiodothyronine (T3), total serum thyroxine (TT4), and maximum thyroxine globulin binding capacity (TBG cap.). In 17 of the infants the same studies were repeated at 1 week of age and in 10 of the 17 at 1 month. The mean T 3 value for the cord sera was 73.1 ± 20.4 ng/100 ml while the mean value for the maternal sera was 204 ± 49.2. The difference in the mean values was highly significant (P < 0.001). The maternal T 3 values are comparable with those of nonpregnant control subjects; those of cord blood fall below normal values. No statistically significant difference was found between the TT4 and TBG cap. values for cord and maternal sera. Both values were higher than the normal nonpregnant control values. At 1 week of age the serum T 3 levels had increased to a mean of 208.4 ± 40.9 ng/100 ml. This mean is significantly different from the one observed in cord sera (P < 0.001). A significant increase in the TT 4 values, mean 12.53 ± 2.2 Mg/100 ml (P < 0.01), was observed by the end of the 1st week. TBG cap. did not change significantly between birth and 1 week of age; by the end of the 1st month of life the serum TT 4 had decreased significantly to a mean of 9.5 ± 2.7 Mg/100 ml (P < 0.05), while the serum T 3 was maintained at a mean level of 228.2 ± 16.9 ng/100 ml, a value not significantly different from the one observed at 1 week of age.
Speculation
The extremely low levels of T 3 in the cord blood in the presence of TT 4 and TBG cap. values equal to those of the maternal blood suggest minimal materno-fetal placental transfer of T 3 . We have postulated that the low fetal T3 is responsible for the high levels of pituitary thyrotropic hormone (TSH) present in cord blood and early in the postnatal period and that the high levels of TT 4 with normal T 3 levels observed by the end of the 1 st week of life indicate defective peripheral deiodination of thyroxine (T 4 ) to T 3 and account for the lack of signs and symptoms of hyperthyroidism. By the end of 1 month of age TT 4 and T 3 values are within normal ranges, which indicates maturation in the metabolic pathway of T 4 and T 3 .
Introduction
Thyroxine metabolism in the neonate is still not completely understood. During the first few days of postnatal life serum hormonal iodine values have been shown to increase significantly [4, 9, 10, 13, 14, 16] . Absence of clinical signs of hyperthyroidism in the presence of laboratory findings suggestive of thyroid hyperactivity continues to be unexplained. Recent evidence that deiodination of (T 4 ) to (T 3 ) is a prominent pathway of T 4 metabolism in normal adults and the development of a sensitive radioimmunoassay for measuring stable T 3 in serum [11] prompted the investigation of this pathway of thyroxine metabolism in the newborn period.
Materials and Methods
Twenty-seven paired maternal and cord sera samples were obtained from normal pregnant women who delivered normal full term infants via the vaginal route without complications. Informed consents were obtained from all subjects in accord with the Helsinki Declaration. Seventeen of the infants were followed for the 1st week of life and 10 of the 17 were followed for the 1st month. All samples were analyzed for TT 4 , T 3 , and TBG cap. The TT 4 was determined by the method of Murphy and Pattee [1, 15] , serum T 3 was measured by a radioimmunoassay developed by Gharib et al. [11] who used a highly specific antibody. The TBG cap. was estimated using the reverse flow electrophoresis in tris-maleate buffer at pH 8.6 [12, 19] . Thyroxine to triiodothyronine (T 4 /T 3 ) ratios were calculated from the values obtained for each sample.
Results
The results in the twenty-seven paired cord and maternal samples are indicated in Table I . Maternal samples had significantly higher T 3 levels compared with cord blood (P < 0.001). The TBG cap. was found to be significantly higher in the mothers' sera than in cord sera (P < 0.05). The T 3 values for the maternal sera are comparable with those of nonpregnant control subjects; however, values for cord blood are well below the accepted normal adult values for our laboratory. The thyroxine to triiodothyronine ratios calculated from these values gave a mean T 4 /T 3 ratio for the cord blood of 135.2 ± 39.2 whereas that for the maternal sera was 55.1 ± 12. The difference in the ratio is highly significant (P < 0.001). The serum levels of triiodothyronine at 1 week of age increased to a mean of 208.4 ± 40.9 ng/100 ml. compared with 73.1 ± 20.4 for the cord blood. Table II is a longitudinal analysis of the T 3 values observed for cord blood at 1 week and at 1 month of age, and those for maternal blood. The A t test was applied to the data [5] : Al denotes the change in T 3 values from cord blood to 1 week of age, A2 the change from 1 week to 1 month, and A3 the overall change from cord to 1 month in the individual infant. The test data and the P values are recorded at the bottom of the table. As can be seen, a significant increase in T 3 levels occurred from birth to 1 week of age but we did not find a significant change in the T 3 levels between 1 week and 1 month of age. Table III is the longitudinal analysis of the TT 4 values in cord blood, at 1 week and at 1 month of age, and those of the maternal blood. The same statistical analysis used in Table II was used for this data. A significant increase in TT 4 values was found to occur between 1 week and 1 month of age. No significant difference was found in the cord values and those at 1 month of age.
Tables IV and V represent the longitudinal data for TBG cap. and the calculated T 4 /T 3 ratios, respectively. As can be seen, there were no significant changes in the TBG cap. between birth and 1 week of age; however, a significant drop took place between 1 week and 1 month. The calculated T 4 /T 3 ratios showed a significant drop between 1 week and 1 month. Overall we found a significant drop in T 4 /T 3 from cord to 1 month.
Discussion
Our findings of elevated TT 4 and TBG cap. in maternal blood are in accordance with the reports of other investigators who have found these changes to be characteristic of pregnancy [16, 20, 22] . The increase in TBG cap. is secondary to estrogen effects and responsible for the elevation in the TT 4 . However, the normal serum T 3 levels observed in the maternal sera indicate that, in contrast to thyroxine, the serum T 3 concentration is not influenced by elevations in TBG cap. These levels are in accordance with the reports that TBG cap. elevation after estrogen therapy does not increase the serum T 3 levels [6] . Cord blood had a significantly lower T 3 concentration than the paired maternal blood. These lower values were observed in the presence of similar concentrations of serum T 4 and TBG Table I . Triiodothyronine (T 3 ), total thyroxine (TT4), thyroxine binding globulin (TBG) concentration, and thyroxine to triiodothyronine ratios (T4/T3) in maternal and cord sera Tj, ng/100 ml TTi, pg/100 ml TBG, jug/100 ml T4/T, cap. in maternal and cord sera and indicate little or no transplacental transfer of T 3 . These findings are in accordance with recent animal experimentation which has demonstrated that in thyroidectomized fetal lambs, transfer of T 3 across the placenta is minimal [7] , but are at a contrast to findings of Dussault el al. [6] , who found levels of T 3 in cord blood to be similar to those of the maternal blood. The difference in the results may be explained by the different methodology used in the two studies. The low levels of T 3 in the presence of normal T 4 levels in cord blood tend to indicate that in the fetus either T 3 secretion by the fetal gland is decreased or that peripheral conversion of T 4 /T 3 is markedly decreased. Pituitary thyrotropic hormone has been shown to be elevated in cord blood and to remain elevated for at least 72 hr after birth [3, 8, 21, 23] . The stimulus for the increased secretion of TSH has not been elucidated. Exposure to cold has been postulated; however, Fisher and Odell [8] demonstrated levels of TSH of the same magnitude as those found in cord blood to be present in blood obtained from scalp veins before delivery. The low circulating 710 MONTALVO ET AL. 1 Ai denotes the change from cord blood to 1 ' to 1 month in the individual infant. reek of age, A 2 the change from 1 week to 1 month, and A 3 the overall change from cord levels of T 3 found in the fetus probably represents the stimulus for TSH hypersecretion in utero and for its persistance in the immediate postnatal period. The present data is in agreement with this hypothesis.
Danowski et al. [4] were first to report the levels of serum protein-bound iodine (PBI) within the newborn period. Their results indicate that within 12 hr after birth the serum PBI in infants was similar to the one present in the maternal blood at the time of delivery with a gradual increase in the levels reaching a peak by the 3rd day and persisting during the entire 1st week of life. The values observed were higher than their accepted standard values for adult euthyroid subjects. Man et al. [13] and Pickering et al. [16] , who measured thyroxine-like butanol-extractable iodine (BEI), demonstrated that the levels of BEI are similar in maternal and cord sera, but that a sharp increase occurs during the 1st week of life which reaches a peak by the 5th day with a return to values similar to those found in cord blood by the 18-20th day of life. Our findings of similar TT 4 levels in cord and maternal sera with a rise in the circulating levels of TT 4 by 1 week of age and a return to levels equal to those found in the cord blood by 1 month of age are in accordance with the previous data for PBI and BEI in the neonatal period. The marked elevation in TT 4 that takes place in the 1st week of life cannot be explained on the basis of changes in TBG cap., inasmuch as TBG cap. values were found not to change significantly during the 1st week of life (Table IV) the decrease in TBG cap. observed to take place between 1 week and 1 month of age could partially, but not completely, explain the TT 4 changes observed between 1 week and 1 month of age (Table III) . We believe a probable explanation for this change to be forthcoming from our data. To our knowledge, serial determinations of serum T 3 levels in the cord blood, at 1 week, and at 1 month of age have not been previously reported.
Braverman el al. [21] were first to demonstrate extrathyroidal conversion of T 4 to T 3 in man. Pittman et al. [18] , in a study of the kinetics of T 4 to T 3 conversion in normal adults, demonstrated that the average daily rate of the extrathyroidal conversion of T 4 to T 3 was 33% of the total thyroxine production and that the amount of T 3 generated by this pathway contributed 41% of daily total T 3 production. This data proves that extrathyroidal conversion of T 4 to T 3 is a major metabolic pathway of T 4 in normal adults. An equally important, but less efficient, metabolic pathway of T 4 in the newborn period can be postulated from our data, which shows that the rapid increase in the circulating levels of T 3 observed by the end of the 1st week of life is associated with abnormally high levels of circulating T 4 without significant changes in TBG T 3 , TT 4 , and T 4 /T 3 in maternal-cord sera 711 cap. A defective peripheral conversion of T 4 to T 3 would account for these findings, as well as for the absence of clinical signs of hyperthyroidism in the presence of high circulating levels of T 4 and TSH. Without kinetic data we cannot exclude defective thyroidal production of T 3 ; however, the ability of the neonatal thyroid to raise the circulating levels of T 4 to abnormally high levels makes defective peripheral conversion of T 4 to T 3 a more attractive hypothesis; the decrease in circulating levels of T 4 to normal values with maintenance of normal circulating levels of T 3 observed by 1 month of age tends to indicate a progressive maturation in the metabolic pathways of T 4 and T 3 . This progressive maturation of enzyme systems is characteristic of the newborn period.
Summary
Our data shows that in the fetus, the T 3 levels are extremely low, whereas levels of TT 4 and TBG cap. are comparable with those of the mother. Maternal T 3 was not elevated compared with values for nonpregnant subjects, which indicates that TBG cap. elevation does not have a significant effect on circulating T 3 levels. The low fetal T 3 levels suggest little placental transfer. The circulating levels of T 3 had a significant increase by the end of the 1st week of life; this increase was associated with abnormally high levels of circulating TT 4 without significant changes in TBG cap. A decrease in TT 4 to levels equal to those found in cord blood but with maintenance of normal circulating T 3 levels was achieved by 1 month of age.
